Both in Pharmaceuticals
Arcturus Therapeutics Holdings vs Galectin Therapeutics
Over the past year ARCT returned −25.7% and GALT returned −8.4%; their daily moves had a correlation of 0.12.
ARCT −25.7% GALT −8.4%Growth of $1, one year, split-adjusted
| Metric | ARCT | GALT |
|---|---|---|
| Price | $13.69 | $3.88 |
| Market cap | $389.1M | $391.3M |
| Today | −0.07% | −0.77% |
| 1 month | −7.2% | −1.8% |
| 6 months | +77.3% | +39.1% |
| Year to date | +123.3% | −6.7% |
| 1 year | −27.1% | −8.1% |
| Revenue growth (YoY) | −89.5% | — |
| Gross margin | 100.0% | — |
| Net margin | −803.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.3× | — |
| Net cash | $191.5M | -$19.8M |
| Dividend yield | — | — |
| Volatility (60d) | 98.9% | 85.7% |
| Short % of float | 24.0% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).